# Joint pain on peptides: what to track, when it shows up, and how to log it

> Peptide joint pain is reported with GH secretagogues; Egrifta's label lists arthralgia at 13% vs 11%, tied to fluid retention. How to log it in Peppy.

Source: https://peppytracker.com/side-effects/joint-pain/
Last updated: 2026-09-02

Joint pain (arthralgia) is reported by many people on growth hormone secretagogues such as ipamorelin, CJC-1295, sermorelin and MK-677. The one label in the group, Egrifta (tesamorelin), lists arthralgia at 13% versus 11% on placebo, myalgia at 6% versus 2%, and explains both as fluid retention from GH release. Log which joints, a 1-5 score and shot timing so a stiff-morning pattern is visible.

## Peptide joint pain: what it is and who reports it

Peptide joint pain is the stiff hands on waking, the achy knees on the stairs, the wrist that complains when you type. On labels it is called arthralgia, and it turns up alongside muscle aches (myalgia) and swelling. It is reported mostly with the growth hormone secretagogues: [Ipamorelin](https://peppytracker.com/compounds/ipamorelin/), [CJC-1295 / Ipamorelin](https://peppytracker.com/compounds/cjc-1295-ipamorelin/), [Sermorelin](https://peppytracker.com/compounds/sermorelin/), [Tesamorelin](https://peppytracker.com/compounds/tesamorelin/) and the oral [MK-677](https://peppytracker.com/compounds/mk-677/). It is not on the GLP-1 labels as a notable reaction.

The one label in the group belongs to Egrifta SV (tesamorelin). Its 26-week table lists:

| Egrifta SV (tesamorelin) label | Drug | Placebo |
| --- | --- | --- |
| Arthralgia | 13% | 11% |
| Pain in extremity | 6% | 5% |
| Myalgia | 6% | 2% |
| Peripheral edema | 6% | 2% |

Two things stand out. The gap between drug and placebo for arthralgia is small, which is a reminder that joints ache for many reasons. And the label does not treat joint pain as a stand-alone event. Its warnings section says fluid retention "manifests as increased tissue turgor and musculoskeletal discomfort resulting in adverse reactions (e.g. edema, arthralgia, and carpal tunnel syndrome) which are either transient or resolve with discontinuation of treatment." Joint pain, [water retention](https://peppytracker.com/side-effects/water-retention/) and [tingling](https://peppytracker.com/side-effects/numbness-tingling/) are one story on that label.

Ipamorelin, CJC-1295, MK-677 and the GHRPs are research compounds with no label and no rate. Sermorelin has no current prescribing information on DailyMed. What exists is what people report: many describe achy or stiff joints in the first few weeks, worse in the morning, and often fading. For healing peptides like [BPC-157](https://peppytracker.com/compounds/bpc-157/) and [TB-500](https://peppytracker.com/compounds/tb-500/) the problem runs the other way; people usually start them because a joint already hurts, so the baseline matters more than the compound.

## When it tends to show up

Many people report joint stiffness starting one to three weeks in, and again for a week or so after a dose increase. Morning is the common worst time, which lines up with night-time dosing of GH secretagogues and with fluid settling overnight. Hands and wrists are named most, then knees and shoulders.

Whether it fades is the question worth answering with data. The Egrifta label says transient or resolves on stopping. Many people on research compounds report the same shape: a few rough weeks, then easier, or clear during an off block and back in the on block. Others report it is dose-dependent and sits at a steady low level. Your log will tell you which of those you are.

The other pattern to look for is whether joint pain, puffiness and tingling rise together. If they do, that is the fluid retention picture the label describes, and it is a different conversation from an isolated sore knee.

## What is worth logging

- **Severity, 1-5, every morning.** Morning is when most people say it peaks, and scoring at a fixed time keeps the numbers comparable.
- **Which joints, in the note.** "Both hands, stiff 20 min", "left knee on stairs". Symmetry matters to a prescriber: both hands is fluid, one hot knee is something else.
- **A baseline before the first shot.** Especially with BPC-157 or TB-500. Log a check-in for a few days before you start so there is something to compare against.
- **Days since your shot and the dose.** Automatic once the shot is logged in the same app.
- **Water retention and tingling alongside.** Score all three. Rows that darken together are the label's pattern.
- **Training and sleep in the note.** A heavy leg day explains a sore knee better than a peptide does. Peppy's feelings scores (energy, sleep) sit in the same check-in.

## When to contact your prescriber

- **One joint that is hot, red, swollen or cannot bear weight.** That is not arthralgia from fluid retention. Same-day call.
- **Joint pain with fever or a rash.** Same.
- **Numbness, tingling or weakness in the hand with wrist pain.** The Egrifta label names carpal tunnel syndrome as a fluid retention reaction. Bring the log.
- **Pain that is not fading after a few weeks, or climbing with each dose change.** The label says these reactions resolve with discontinuation; whether to change anything is your prescriber's call, and a week-by-week chart makes it a short one.
- **A history of arthritis or a joint replacement.** New joint pain on a GH secretagogue is something that specialist wants to know about.

## How to do this in Peppy

1. **Turn joint pain on.** Open Settings ▸ Tracking and toggle Joint pain. It is off by default. Toggle Water retention and Numbness / tingling too if you want the full picture.
2. **Log a baseline.** Before the first shot, open the check-in row on the Today tab for a few days and score joint pain honestly. Check-ins do not need a dose logged that day.
3. **Score it every morning in the daily check-in.** Set joint pain 1-5, name the joints in the note, and set your energy and sleep feelings while you are there.
4. **Log every shot on the body map.** Tap the dose on the Today tab, pick the site, confirm the time. The dose saves with the shot, so step-ups from your titration ladder (Pro) show as markers on the charts.
5. **Read the weekly heat-map in Progress (Pro).** Joint pain, water retention and numbness sit as rows on one week axis with step-ups and cycle boundaries marked. Three rows darkening together after a step-up is the finding. Free users see the chart blurred.
6. **Use the Calendar for the off-cycle test.** If you run cycles (Pro), the week strip shows the skipped days. Flip through check-ins either side of the boundary and compare scores.
7. **Export before an appointment (Pro).** Settings ▸ Export gives a PDF or CSV of every dose and check-in, including notes.

Related: [water retention](https://peppytracker.com/side-effects/water-retention/), [numbness and tingling](https://peppytracker.com/side-effects/numbness-tingling/), the [BPC-157 tracker](https://peppytracker.com/trackers/bpc-157-tracker/) and the [side-effects tracking guide](https://peppytracker.com/guides/track-glp-1-side-effects-food-noise/).

## Frequently asked

### Does ipamorelin cause joint pain?

Ipamorelin is a research compound with no FDA label, so there is no rate. Many people report stiff or achy joints, often hands, wrists and knees, in the first weeks or after a dose increase. The tesamorelin label's explanation, fluid retention causing musculoskeletal discomfort, is the usual reason given, but it has not been measured for ipamorelin.

### Why do growth hormone peptides make joints ache?

The Egrifta label says fluid retention from increased GH secretion manifests as increased tissue turgor and musculoskeletal discomfort, listing edema, arthralgia and carpal tunnel syndrome as examples. Swollen tissue around a joint is a plausible reason it feels stiff. That is a label statement about tesamorelin, applied to other GH secretagogues by analogy.

### Is peptide joint pain permanent?

The Egrifta label says these fluid retention reactions are either transient or resolve with discontinuation of treatment. Many people on other GH secretagogues report the same: easing after a few weeks, or clearing during an off cycle. A daily score is how you find out whether yours is following that pattern.

### Do BPC-157 or TB-500 cause joint pain?

Both are research compounds with no label. They are more often taken because of a sore joint than reported as causing one, which makes logging harder: you need a baseline score before the first shot to tell either way. Peppy lets you log check-ins on days with no dose for exactly that reason.

### When is joint pain on a peptide a reason to call the doctor?

A single hot, red, swollen joint, joint pain with fever, pain after an injury, or pain that stops you using the joint are not tracking questions and need a same-day call. Numb or tingling fingers with wrist pain fits the carpal tunnel the Egrifta label mentions and is worth raising.

---

Peppy is a tracking tool, not medical advice. Dose calculations are mathematical conversions only. Always follow your prescriber's instructions and verify every draw-up yourself.

Peppy is a free iPhone app (Pro subscription optional). App Store: https://apps.apple.com/us/app/peptide-tracker-peppy/id6775005514